According to the Global Burden of Disease Project, skin diseases such as psoriasis, eczema, skin cancer, and vitiligo continue to be the fourth-leading cause of nonfatal disease burden worldwide and ...
Delivery of Biologics Through the Transdermal Route. Self-Administration and Home Care. This study involved the extensive use of both primary and secondary sources. The research process involved the ...
Arcutis Biotherapeutics has terminated a phase 2a clinical trial of its vitiligo candidate over concerns the topical formulation will fail to get enough active drug to targets in the skin.
Tropical disease drug discovery is an interdisciplinary field at the intersection of medicinal chemistry, computational biology, and global health. Despite ...
Arcutis Biotherapeutics has topped up its bank balance ahead of a critical year. With 2022 bringing a trio of pivotal clinical trial readouts and potentially a FDA approval, the topical drug delivery ...
According to a new market research report "Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, ...
News-Medical.Net on MSN
Microneedle patches enhance acne treatment with dual drug delivery
Acne vulgaris affects a large proportion of adolescents and young adults and can lead to long-term scarring and psychological distress. Its pathogenesis involves excessive sebum production, bacterial ...
In a press release issued on February 15, Psycheceutical Bioscience, in partnership with iNGENū, a contract research organization in the cannabinoid and psychedelic space, has announced their ...
In 1998 I was exposed to the term “disruptive innovation” for the first time. I read a wonderful book, “The Innovator’s Dilemma” by Clayton Christensen, where I learned the difference between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results